150 related articles for article (PubMed ID: 8369613)
1. The modulation by L-leucovorin of 5-fluorouracil antitumor activity on human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Takahara T; Takeuchi T; Yamaguchi H; Furukawa T; Teramoto T; Kodaira S; Ishibiki K
Surg Today; 1993; 23(7):615-20. PubMed ID: 8369613
[TBL] [Abstract][Full Text] [Related]
2. Dual modulation by l-leucovorin and recombinant human interferon alpha 2a of 5-fluorouracil antitumor activity against the human colon carcinoma xenograft Co-4.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Teramoto T; Kitajima M
J Interferon Cytokine Res; 1995 Dec; 15(12):1089-93. PubMed ID: 8746791
[TBL] [Abstract][Full Text] [Related]
3. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
[TBL] [Abstract][Full Text] [Related]
4. Modulation by l-leucovorin of 1-hexylcarbamoyl-5-fluorouracil antitumor activity on human gastric and colon carcinomas serially transplanted into nude mice.
Kubota T; Kase S; Furukawa T; Tanino H; Kuo TH; Saikawa Y; Nishibori H; Ishibiki K; Kitajima M; Mabuchi K
Anticancer Res; 1992; 12(5):1549-53. PubMed ID: 1444220
[TBL] [Abstract][Full Text] [Related]
5. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
6. Interferon alpha-2a shows antitumor activity in combination with 5-fluorouracil against human colon carcinoma xenografts: a study in reference to thymidylate synthetase activity inhibition.
Kubota T; Inada T; Ogata Y
Surg Today; 1992; 22(5):481-3. PubMed ID: 1421872
[TBL] [Abstract][Full Text] [Related]
7. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
Iigo M; Nishikata K; Hoshi A
Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
[TBL] [Abstract][Full Text] [Related]
8. [Biochemical modulation applied to experimental cancer chemotherapy].
Nakamura Y
Nihon Jibiinkoka Gakkai Kaiho; 1996 Nov; 99(11):1694-704. PubMed ID: 8969073
[TBL] [Abstract][Full Text] [Related]
9. In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.
Nadal JC; Van Groeningen CJ; Pinedo HM; Peters GJ
Biomed Pharmacother; 1988; 42(6):387-93. PubMed ID: 3064823
[TBL] [Abstract][Full Text] [Related]
10. Influence of dose of [6RS]leucovorin on reduced folate pools and 5-fluorouracil-mediated thymidylate synthase inhibition in human colon adenocarcinoma xenografts.
Houghton JA; Williams LG; Cheshire PJ; Wainer IW; Jadaud P; Houghton PJ
Cancer Res; 1990 Jul; 50(13):3940-6. PubMed ID: 2354443
[TBL] [Abstract][Full Text] [Related]
11. Elevation of thymidylate synthase following 5-fluorouracil treatment is prevented by the addition of leucovorin in murine colon tumors.
Van der Wilt CL; Pinedo HM; Smid K; Peters GJ
Cancer Res; 1992 Sep; 52(18):4922-8. PubMed ID: 1516048
[TBL] [Abstract][Full Text] [Related]
12. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
[TBL] [Abstract][Full Text] [Related]
13. Antitumour activity, toxicity and inhibition of thymidylate synthase of prolonged administration of 5-fluorouracil in mice.
Codacci-Pisanelli G; van der Wilt CL; Pinedo HM; Franchi F; Noordhuis P; Braakhuis BJ; van Laar JA; Peters GJ
Eur J Cancer; 1995; 31A(9):1517-25. PubMed ID: 7577082
[TBL] [Abstract][Full Text] [Related]
14. Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.
Nadal JC; van Groeningen CJ; Pinedo HM; Peters GJ
Invest New Drugs; 1989 Jul; 7(2-3):163-72. PubMed ID: 2793368
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion.
Arkenau HT; Rettig K; Porschen R
Int J Colorectal Dis; 2005 May; 20(3):258-61. PubMed ID: 15549327
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of fluoropyrimidines and thymidylate synthetase inhibition.
Kubota T; Fujita S; Kodaira S; Yamamoto T; Josui K; Arisawa Y; Suto A; Ishibiki K; Abe O; Mabuchi K
Jpn J Cancer Res; 1991 Apr; 82(4):476-82. PubMed ID: 1904428
[TBL] [Abstract][Full Text] [Related]
17. Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin.
Rustum YM
Cancer; 1989 Mar; 63(6 Suppl):1013-7. PubMed ID: 2783877
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5-fluorouracil, leucovorin, and glucarate in rat colon-tumor explants.
Schmittgen TD; Koolemans-Beynen A; Webb TE; Rosol TJ; Au JL
Cancer Chemother Pharmacol; 1992; 30(1):25-30. PubMed ID: 1586977
[TBL] [Abstract][Full Text] [Related]
19. Combined modulation by leucovorin and alpha-2a interferon of fluoropyrimidine mediated growth inhibition.
Sinnige HA; Timmer-Bosscha H; Peters GF; De Vries EG; Mulder NH
Anticancer Res; 1993; 13(5A):1335-40. PubMed ID: 8239504
[TBL] [Abstract][Full Text] [Related]
20. Synergism and lack of cross-resistance between short-term and continuous exposure to fluorouracil in human colon adenocarcinoma cells.
Sobrero AF; Aschele C; Guglielmi AP; Mori AM; Melioli GG; Rosso R; Bertino JR
J Natl Cancer Inst; 1993 Dec; 85(23):1937-44. PubMed ID: 8230285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
